Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

Detalles Bibliográficos
Autores principales: Wang, Yue-qin, Shen, Ai-jun, Sun, Jing-ya, Wang, Xin, Liu, Hong-chun, Zhang, Min-min, Chen, Dan-qi, Xiong, Bing, Shen, Jing-kang, Geng, Mei-yu, Zheng, Min, Ding, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471402/
https://www.ncbi.nlm.nih.gov/pubmed/32081977
http://dx.doi.org/10.1038/s41401-019-0341-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471402/
https://www.ncbi.nlm.nih.gov/pubmed/32081977
http://dx.doi.org/10.1038/s41401-019-0341-6

Ejemplares similares